ARCHIVES

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

This article is from The Cancer Letter archive.

Vol. 09 No. 18 | May 6, 1983

Download PDF Visit The Full Archive

Related Articles

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

NCI RFAs Available

May 5, 2000

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991